[1]
SHEIKH, M. et al. 2025. PHYTOSOME TECHNOLOGY IN CANCER TREATMENT ENHANCES THE BIOAVAILABILITY OF SECONDARY METABOLITES. International Journal of Applied Pharmaceutics. 17, 6 (Nov. 2025), 67–77. DOI:https://doi.org/10.22159/ijap.2025v17i6.54665.